DC-Y13-27

Produktübersicht

• Artikelname: DC-Y13-27
• Artikelnummer: MCE-HY-154919
• Hersteller Artikelnummer: HY-154919
• Alternativnummer: MCE-HY-154919-25MG,MCE-HY-154919-50MG,MCE-HY-154919-10MMX1ML,MCE-HY-154919-5MG,MCE-HY-154919-100MG,MCE-HY-154919-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

DC-Y13-27 is a DC-Y13 derivative and YTHDF2 inhibitor (KD: 37.9 µM). DC-Y13-27 inhibits YTHDF2, restores FOXO3 and TIMP1 protein levels, and reduces MMP1/3/7/9 expression. DC-Y13-27 induces Pyroptosis and increases IL-1beta secretion. DC-Y13-27 reduces intervertebral disc degeneration and enhances the response to radiotherapy in colon cancer and melanoma. DC-Y13-27 has antitumor activity against breast cancer[1][2][3].

Produkteigenschaften

• Molekulargewicht: 270.31
• Reinheit: 99.52
• Formel: C14H10N2O2S
• Target-Kategorie: FOXO,Interleukin Related,MMP,Pyroptosis,YTHDF

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound